Vivo Capital, LLC Delcath Systems, Inc. Transaction History
Vivo Capital, LLC
- $683 Million
- Q3 2024
A detailed history of Vivo Capital, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 997,005 shares of DCTH stock, worth $11.9 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
997,005
Previous 1,666,746
40.18%
Holding current value
$11.9 Million
Previous $14 Million
35.47%
% of portfolio
1.32%
Previous 2.06%
Shares
5 transactions
Others Institutions Holding DCTH
# of Institutions
72Shares Held
7.53MCall Options Held
198KPut Options Held
41.7K-
Aigh Capital Management LLC Baltimore, MD1.78MShares$21.3 Million6.51% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$13.3 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA337KShares$4.03 Million0.57% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny312KShares$3.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA252KShares$3.01 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $103M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...